Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction

Overview of attention for article published in BMC Cardiovascular Disorders, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 1 news outlet

twitter: 5 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 15 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Study: Sacubitril/Valsartan Led to Fibrosis Improvements in HFrEF

AJMC, 20 May 2022

This study evaluated levels of 4 biomarkers associated with heart failure with reduced ejection fraction (HFrEF) before and…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.